Efficacy and safety of triple combination cream (0.01% fluocinolone acetonide+4% hydroquinone+0.05% tretinoin) and hydroquinone 4% cream in the treatment of moderate to severe melasma

被引:0
|
作者
Cestari, T
Hassun, K
Sittart, A
机构
[1] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[2] Univ Fed Sao Paulo, Sao Paulo, Brazil
[3] Hosp Servidor Publ Estadual, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:P168 / P168
页数:1
相关论文
共 46 条
  • [41] Efficacy and safety of a novel picosecond laser using combination of 1064 and 595nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial
    Choi, Young-Jun
    Nam, Jae-Hui
    Kim, Jung Yup
    Min, Joon Hong
    Park, Kui Young
    Ko, Eun Jung
    Kim, Beom Joon
    Kim, Won-Serk
    LASERS IN SURGERY AND MEDICINE, 2017, 49 (10) : 899 - 907
  • [43] Clinical evaluation of the efficacy and tolerance of a formulation containing hydroxyphenoxy propionic acid, ellagic acid, yeast extract, and salicylic acid in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone and 0.025% tretinoin cream
    Yatskayer, Margarita
    Dahl, Amanda
    Oresajo, Christian
    Chen, Nannan
    Raab, Susana
    Krol, Yevgeniy
    Draelos, Zoe
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB158 - AB158
  • [44] Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: A randomized controlled split-face trial
    Huh, Sun Young
    Shin, Jung-Won
    Na, Jung-Im
    Huh, Chang-Hun
    Youn, Sang-Woong
    Park, Kyoung-Chan
    JOURNAL OF DERMATOLOGY, 2010, 37 (04): : 311 - 315
  • [45] Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial
    Liang, Surong
    Shang, Shuai
    Zhang, Wensi
    Tan, Ansheng
    Zhou, Boyang
    Mei, Xueling
    Li, Linfeng
    FRONTIERS IN MEDICINE, 2023, 10
  • [46] Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor-and analyst-blinded, randomized controlled trial with a short-term follow-up
    Lajevardi, Vahideh
    Ghayoumi, Afsaneh
    Abedini, Robabeh
    Hosseini, Hamed
    Goodarzi, Azadeh
    Akbari, Zahra
    Hedayat, Kosar
    JOURNAL OF COSMETIC DERMATOLOGY, 2017, 16 (02) : 235 - 242